The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts. The grant supports research to elucidate the molecular mechanisms of DNA double-strand break repair by homologous recombination, a high-fidelity DNA repair pathway that is critical for suppressing cancer development. Over the 5-year project...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), is funding research at the Sloan-Kettering Institute for Cancer Research to investigate the molecular mechanisms of eukaryotic chromosome replication. The $1,350,554.00 award will support a 5-year research project that aims to elucidate the intrinsic mechanisms of the eukaryotic DNA replication machinery and its response to various...
This Project Grant award of $487,393.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports research on backup DNA repair mechanisms in homologous recombination deficient (HRD) cancers. The research aims to determine the role of key proteins like RAD52, HELQ, and POLQ in backup double-strand break repair pathways when the primary homologous recombination pathway is inactivated in certain cancer types. The goal is to identify...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, supports research to understand the fundamental mechanisms of genome stability. The $750,730 award, effective August 16, 2024 through July 31, 2029, will enable the University of Illinois to pursue two key projects: Investigating the role of the smallest subunit of the Origin Recognition Complex (ORC), ORC6, in DNA replication...
This $390,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports research to elucidate the mechanisms underlying DNA double-strand break repair at Thomas Jefferson University's Sidney Kimmel Medical College. The project aims to use cutting-edge microscopy and biochemical techniques to map the dynamics of DNA repair proteins and better understand how the multi-enzyme complex...
This Project Grant award of $254,919 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) federal grant program, aims to advance the understanding of regulatory mechanisms that ensure accurate transmission of the genome during cell division. The key focus areas are: 1) Investigating how cells regulate the loading and removal of the Mini-Chromosome Maintenance (MCM) complex to prevent incomplete DNA replication, a major...
This Project Grant award from the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences, under the Biological Sciences program (CFDA 47.074), provides $910,000 over 4 years to Weill Medical College of Cornell University to conduct research on the regulation of DNA repair mechanisms and transcription at telomeres. The research aims to improve understanding of how genetic information is protected at chromosome ends, which is critical for cell and organism health. The...
This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $350,000 to the University of Iowa to support research on the mechanisms involved in the propagation of chromosome fragments in the germline. The 3-year project aims to investigate how DNA breaks that occur during the formation of egg and sperm cells are stabilized and passed on to the next generation. The research will be conducted using the model organism C. elegans and will...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $358,000 in funding to Brigham & Women's Hospital Inc. to conduct research on overcoming epigenetic barriers to somatic cell reprogramming by the XPC DNA repair complex. The key focus of the research is to understand how the XPC protein regulates DNA demethylation and gene expression changes mediated by the TDG enzyme, and how...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $1,637,500.00 to The Johns Hopkins University to conduct research on the mechanisms controlling DNA repair pathway choice. The project aims to investigate how chromatin dynamics and nuclear RNA modifications regulate DNA repair across different cell states and physiological contexts. Specifically, the research will...